Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial.

Lähteenmäki R, Puustinen J, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Räihä I, Kivelä SL.

Br J Clin Pharmacol. 2014 Jun;77(6):975-85. doi: 10.1111/bcp.12294.

2.

Effect of withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotic agents on cognition in older adults.

Puustinen J, Lähteenmäki R, Polo-Kantola P, Salo P, Vahlberg T, Lyles A, Neuvonen PJ, Partinen M, Räihä I, Kivelä SL.

Eur J Clin Pharmacol. 2014 Mar;70(3):319-29. doi: 10.1007/s00228-013-1613-6.

PMID:
24337417
3.

Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.

Roehrs TA, Randall S, Harris E, Maan R, Roth T.

J Psychopharmacol. 2012 Aug;26(8):1088-95. doi: 10.1177/0269881111424455.

4.

Handgrip strength and balance in older adults following withdrawal from long-term use of temazepam, zopiclone or zolpidem as hypnotics.

Nurminen J, Puustinen J, Lähteenmäki R, Vahlberg T, Lyles A, Partinen M, Räihä I, Neuvonen PJ, Kivelä SL.

BMC Geriatr. 2014 Nov 21;14:121. doi: 10.1186/1471-2318-14-121.

5.

[Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].

Lemoine P, Touchon J, Billardon M.

Encephale. 1997 Jul-Aug;23(4):290-9. French.

PMID:
9417395
6.

Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.

Sleep. 2009 Mar;32(3):351-60.

7.

Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life.

Curran HV, Collins R, Fletcher S, Kee SC, Woods B, Iliffe S.

Psychol Med. 2003 Oct;33(7):1223-37.

PMID:
14580077
8.

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.

Sleep Med. 2006 Jun;7(4):312-8.

PMID:
16709464
9.
10.
11.
12.

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

Darker CD, Sweeney BP, Barry JM, Farrell MF, Donnelly-Swift E.

Cochrane Database Syst Rev. 2015;(5):CD009652. Review.

PMID:
26106751
14.

Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.

Kunz D, Bineau S, Maman K, Milea D, Toumi M.

Expert Opin Pharmacother. 2012 Jan;13(1):9-16. doi: 10.1517/14656566.2012.638284.

PMID:
22107732
15.

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects.

Voderholzer U, Riemann D, Hornyak M, Backhaus J, Feige B, Berger M, Hohagen F.

Eur Arch Psychiatry Clin Neurosci. 2001 Jun;251(3):117-23.

PMID:
11697572
16.

Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.

Wade AG, Crawford G, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N.

Curr Med Res Opin. 2011 Jan;27(1):87-98. doi: 10.1185/03007995.2010.537317.

PMID:
21091391
17.

Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Sivertsen B, Omvik S, Pallesen S, Bjorvatn B, Havik OE, Kvale G, Nielsen GH, Nordhus IH.

JAMA. 2006 Jun 28;295(24):2851-8.

PMID:
16804151
18.

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

Elie R, Rüther E, Farr I, Emilien G, Salinas E.

J Clin Psychiatry. 1999 Aug;60(8):536-44.

PMID:
10485636
19.

Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.

Darker CD, Sweeney BP, Barry JM, Farrell MF, Donnelly-Swift E.

Cochrane Database Syst Rev. 2015 May 11;5:CD009652. [Epub ahead of print]

PMID:
26114884
20.

Sleep complaints: Whenever possible, avoid the use of sleeping pills.

[No authors listed]

Prescrire Int. 2008 Oct;17(97):206-12.

PMID:
19536941

Supplemental Content

Support Center